The Morningstar US Active/Passive Barometer for 2024 provides insightful data on how active funds have been performing compared to their passive counterparts. Over the past decade, active funds have faced challenges, marked by consistent outflows and difficulty in outperforming passive funds. However, the total assets in US passive mutual funds and ETFs exceeded those of active funds for the first time.

Despite these trends, active management is far from obsolete. Active managers have managed to compensate for outflows through strategies like asset appreciation and fee bases during lucrative market conditions. Yet, the changing market environment could pose challenges.

Key Findings from the Morningstar US Active/Passive Barometer:

  • Success Rates: In 2024, active small-cap managers had a higher success rate (43%) compared to mid-cap (37%) and large-cap (37%) managers. However, over the last decade, only 7% of active large-cap funds survived and outperformed their passive counterparts.

  • Challenges in Large-Cap Equity: Only 7% of active US large-cap funds managed to survive and outperform passive competitors over the past decade. However, there was an improvement in their performance in 2024, with a success rate increase to 37%.

  • Success in Small-Cap Categories: Active small-cap funds performed better over the long term, with a 43% success rate in 2024, suggesting that the market is less efficiently priced in this category.

  • Real Estate and Fixed Income: Actively managed US real estate funds displayed the highest success rate among all categories with 47% succeeding over the past decade. In fixed income, active bond managers saw increased success rates in 2024, particularly in intermediate core bonds, corporate bonds, and high-yield bonds.
Active management remains a viable option for certain categories, notably in real estate and fixed income markets. The Morningstar report provides a comprehensive analysis that aids financial advisors in understanding the dynamics of active versus passive fund performance.

The original article on Morningstar discusses these findings in detail, highlighting the importance of the Active/Passive Barometer as a tool for evaluating investment strategies, offering insights into fees, market dynamics, and success rates across various fund categories.

Chart of actively managed us real estate funds

Global real estate funds success rate decline chart

Rolling success rates for active intermediate bond funds

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Gene Editing: A Promising Frontier in Biotechnology

Gene editing technology is swiftly emerging as a transformative force in both healthcare and agriculture, particularly through tools like CRISPR-Cas9, which offer precise methods to modify genes and promise to revolutionize treatment for genetic disorders, cancer, and infectious diseases.

Empowering the Gig Economy: AXA’s Tailored Protection

Angela Wong, Chief Marketing and Customer Officer at AXA Hong Kong & Macau, underscores the critical need for comprehensive insurance solutions for gig workers.

By |November 24, 2024|Categories: Article, Business, Insurance|Tags: , |0 Comments

Ethical Deployment of AI in Healthcare: AMA’s Guiding Strategies

The AMA highlights that AI's integration must be guided by the fundamental principles of medical ethics: patient autonomy, beneficence, nonmaleficence, and justice.

By |November 24, 2024|Categories: Article, Healthcare, Technology Ethics|Tags: , |0 Comments

AI’s Role in Revolutionizing Medical Education

AI, which simulates human intelligence, is reshaping various sectors, particularly healthcare. The ability to perform complex tasks, such as diagnostics and personalized healthcare, is no longer confined to human capabilities alone.

By |November 23, 2024|Categories: Article, Education, Technology|Tags: , |0 Comments

AI Chatbots in Chronic Disease Diagnosis

A recent study published in Nature on July 25, 2024, unveils a cutting-edge chatbot named Chat Ella, designed to assist in the diagnosis of chronic diseases.

Revolutionizing Genetic Research with CRISPR-Cas Technology

CRISPR-Cas technology is not just a tool but a gateway to understanding the genetic influences on diseases.